Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels

NCT02648269 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: SEL-110
BIOLOGICAL: SEL-212
BIOLOGICAL: SEL-037

Sponsor

Selecta Biosciences, Inc.